The Juv'ae Journal | Empowering Nurses, Scaling Clinics, Transforming Lives

NSW Cosmetic Injectable Rules 2026: Is Your Clinic Compliant?

Written by Jacinta King | Jul 6, 2026, 12:02:18 AM

The NSW Government has released the Medicines, Poisons and Therapeutic Goods Regulation 2026, introducing a new regulatory framework for the prescribing, supply, storage and administration of medicines across NSW. From 5 November 2026, cosmetic nurses, prescribers and clinic owners must comply with a dedicated section on cosmetic injectables, including a requirement that every direction states the area of the face or body to be treated.

Many of the principles reflect existing expectations around safe practice, but the new Regulation sets out in much greater detail how clinical governance must be demonstrated and documented, and breaches are now offences. Here’s what the changes mean for your clinic, and how Juv’ae360 already supports compliant practice.

Cosmetic Medicine Gets An Expanded Dedicated Section

Cosmetic use substances have been regulated in NSW for some time, but Part 9 of the new Regulation consolidates and expands these requirements into a single, dedicated section. Spanning four pages, Part 9 sets out specific requirements relating to: 

  • Administration of cosmetic use substances

  • Administration by nurses under the direction of medical practitioners and nurse practitioners

  • Prescribing directions

  • Record keeping

  • Storage

  • Duties of responsible providers and staff

  • Category 1 and category 2 offence requirements

This reflects the continued evolution of cosmetic medicine as a highly regulated area of healthcare, with greater emphasis on governance, accountability and patient safety.

Every Direction Must Now Specify the Treatment Area

Under section 90 of the new Regulation, a written direction from a medical practitioner or nurse practitioner must state, for each administration, the name and form of the substance, the quantity, and the part of the patient’s face or body to which it will be administered.

In practice, a direction can no longer simply authorise a product and a quantity. It must say where that product will be used. If a patient asks for an additional area to be treated during their appointment and it is not listed on the current direction, the nurse should not treat it until the prescriber has reviewed the patient and issued an updated direction.

What Does This Mean for Cosmetic Practitioners & Clinic Owners?

The Regulation places increased emphasis on:

  • Clinical governance

  • Prescriber oversight

  • Accurate patient records

  • Medicine traceability

  • Documentation standards

  • Audit readiness

For cosmetic practitioners, compliance extends beyond administering medicines safely. There is now a stronger expectation that every stage of the patient's clinical journey can be clearly demonstrated through accurate documentation, appropriate prescribing, and effective clinical oversight.

Who Can Give a Direction

Under section 88, only a medical practitioner or nurse practitioner can give a direction for a nurse to administer a cosmetic use substance.

Section 87(2) confirms that a registered nurse with an endorsement, such as a designated RN prescriber, is not treated as an authorised practitioner for the purposes of Part 9. A designated RN prescriber therefore cannot direct the administration of cosmetic use substances, or administer them on their own authority.

For cosmetic nurses considering postgraduate study to become a designated RN prescriber, this is an important consideration. In NSW, the endorsement will not authorise prescribing for cosmetic purposes.

Record Keeping Is More Important Than Ever

One of the strongest themes throughout the new Regulation is the importance of maintaining complete and accessible clinical records. This includes:

  •  Current written directions, including the treatment area for each administration 

  •  A written record of every administration, including the batch number 

  •  Copies of every direction and administration record, kept by the responsible provider 

  •  Records kept for at least 2 years and available for inspection on demand 

  • Complete clinical notes
  • Clear evidence of prescriber oversight

The Regulation also requires nurses to give a copy of each administration record to the prescribing medical practitioner or nurse practitioner, and to the responsible provider (section 88(3)(d)). Prescribers must keep a copy of every direction they give and provide a copy to the responsible provider (section 91), who must then keep copies of all directions and administration records (section 93(2)).

With records moving between the nurse, the prescriber and the clinic, many aesthetic clinics will find it easier to meet these obligations by working within a single clinical system, rather than relying on multiple disconnected platforms or paper records. 


New Requirements Are Now Supported by Offences

A notable change within the Regulation is that section 94 sorts the Part 9 obligations into category 1 and category 2 requirements.

These are not simply recommendations or best practice guidelines. Contravening either category is an offence under section 54(3) of the Medicines, Poisons and Therapeutic Goods Act 2022.

Category 1 requirements are the most serious. They include only administering a cosmetic use substance in accordance with a valid direction or a lawful prescription, using only legitimately supplied products, having emergency equipment available, and the prescriber personally reviewing the patient. They also include the responsible provider’s duties to have risk management policies in place and to make sure nurses are trained for medical emergencies. The maximum penalty is 200 penalty units or 6 months’ imprisonment for an individual, and 1,000 penalty units for a corporation.

Category 2 requirements cover documentation and storage, including the content of directions, keeping records and copies, and storing substances correctly. The maximum penalty is 50 penalty units for an individual and 250 penalty units for a corporation. Some of these breaches can also attract on-the-spot penalty notices.

 The obligations extend beyond the treating nurse. The Regulation defines a responsible provider as the person carrying on the business of administering cosmetic use substances. This means clinic owners carry direct legal responsibility, alongside the nurses and prescribers working in the clinic. 

How Juv'ae360 Already Supports Compliant Practice

As regulatory expectations continue to evolve, technology plays an increasingly important role in supporting compliant clinical practice.

Many of the governance principles outlined in the new Regulation have already been incorporated into Juv'ae360, Juv'ae's proprietary software platform designed specifically for cosmetic medicine.

Juv'ae360 helps cosmetic nurse practitioners:

  • Support compliant prescribing workflows

  • Maintain a complete digital clinical record

  • Record medicine batch numbers and treatment details

  • Give prescribing practitioners visibility of patient records

  • Maintain records that are secure and audit-ready

Rather than adding administrative burden, the platform has been designed to embed compliance into everyday clinical practice while supporting safe, high-quality patient care.

If you're using Juv'ae360, you've got a head start on what this Regulation now expects.

What's Next: Education, Webinars and Practical Resources

The new Regulation represents an important step in strengthening clinical governance across cosmetic medicine in New South Wales.

Over the coming weeks, our Clinical Governance Committee will be releasing practical resources to help cosmetic nurses and aesthetic clinic owners understand the new requirements before they come into effect on 5 November 2026. This will include:

  • Plain English summaries of the Regulation

  • Practical compliance resources

  • Guidance on implementing the changes in everyday clinical practice

  • Juv'ae360 nurses get exclusive access to these sessions as part of the platform.

As the industry continues to evolve, our goal remains the same: to support practitioners with practical education, strong clinical governance and systems that help deliver safe, compliant patient care.

In the meantime, visit the NSW Health website for updates, or Download the Medicines, Poisons and Therapeutic Goods Regulation 2026 (NSW) here (updated as of 6/7/2026).

This article provides general information only and should not be relied upon as legal advice. Cosmetic nurses and clinic owners should refer to the Medicines, Poisons and Therapeutic Goods Act 2022 and Medicines, Poisons and Therapeutic Goods Regulation 2026 for full requirements. 

Not a Juv'ae nurse? Join the community that supports you through regulatory change, clinical governance and everyday compliance, so you're never navigating it alone